Hineloran
Hineloran je leki koji deluje kao selektivni dopaminski agonist za D2 podtipe.[1][2][3]
 | |
| IUPAC ime | |
|---|---|
(5aR,9aR)-6-propil-5a,7,8,9,9a,10-heksahidro-5H-pirido[2,3-g]hinazolin-2-amin | |
| Identifikatori | |
| CAS broj | 97548-97-5  |
| ATC kod | none |
| PubChem | CID 57242 |
| UNII | Z0X4VT3Y1Q |
| KEGG | D05677 |
| ChEMBL | CHEMBL155731 |
| Hemijski podaci | |
| Formula | C14H22N4 |
| Molarna masa | 246,350 g/mol |
| |
Reference уреди
- ^ Caine SB, Negus SS, Mello NK, Patel S, Bristow L, Kulagowski J, Vallone D, Saiardi A, Borrelli E (2002). „Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists”. Journal of Neuroscience. 22 (7): 2977—88. PMID 11923462.
- ^ Gasior M, Paronis CA, Bergman J (2004). „Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys”. The Journal of Pharmacology and Experimental Therapeutics. 308 (1): 249—59. PMID 14563783. doi:10.1124/jpet.103.052795.
- ^ Brooks JM, Sarter M, Bruno JP (2007). „D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex”. Neuropharmacology. 53 (3): 455—63. PMC 2000917
. PMID 17681559. doi:10.1016/j.neuropharm.2007.06.006.
Vidi još уреди
Spoljašnje veze уреди
 | Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |
